Biological E Hopes to Roll Out Covid Vaccine Corbevax by November-end; US To Finance $50 million Deal For Vax Production

Biological E’s anti-coronavirus shot, Corbevax, is a RBD protein sub-unit vaccine and is currently undergoing phase 2/3 clinical trials on adults.

Source: Top India News- News18.com